MEROVA Health, a digital pioneer in diabetes prevention, has reached a new milestone by securing a total investment of HUF 100 million. Hiventures joined the round with HUF 50 million, alongside Óbuda Uni Venture Capital (OUVC) with HUF 35 million, as well as the First Central European Hardware Accelerator and Szakacsits Ventures. The new funding will enable the development of MEROVA’s AI-powered patient application, MEROVA – Zia, the enhancement of its client management system, MEROVA – Anton, and the launch of insurance pilot programs.
MEROVA supports both patients and preventive care professionals. The Anton client management system provides specialists with a mobile-friendly tool that simplifies administration and enables the creation of personalized follow-up plans. These plans are synchronized with the patient-side application, Zia, which helps users maintain a healthy lifestyle through continuous digital support.
The AI-driven Zia analyzes medical histories, treatment plans, and daily logs, linking meal photos with blood sugar data to provide a clear picture of what most affects glucose levels. Over time, the data builds a truly personalized digital assistant that patients can also share with their dietitians.
By connecting Anton and Zia, prevention becomes fully integrated: professionals and patients can work together to prevent complications, while every change can be accurately tracked.
“MEROVA offers a complex digital solution to an extremely timely and socially important problem. We were convinced by the founders’ strong professional background and entrepreneurial mindset, as well as by the project’s outstanding social impact – thousands of amputations could be prevented each year through regular follow-up and timely intervention. This is not only a good investment, but the right decision,” said Veszna Várhelyi, Investment Director at OUVC.
“At Hiventures, we place special emphasis on supporting developments that create both business value and real social impact. MEROVA’s solution is a prime example of how technology can meaningfully improve our everyday lives and contribute to a more livable, safer, and sustainable future. We are proud to be part of this journey as investors,” added László Hradszki, CEO of Hiventures.
MEROVA’s data-driven prevention approach follows the entire patient journey, enabling timely and personalized interventions. Its solution is also cost-effective: by preventing complications, it can generate substantial savings for healthcare systems and insurers. Its life-saving impact is also significant, as diabetes complications cause 6.7 million deaths worldwide each year. The system functions as a digital “protective layer,” reducing the risk of severe complications and providing doctors with complete medical histories when treatment is required.
The investment will fund three key developments. First, MEROVA will further develop Zia, its AI-based application providing daily health support and patient monitoring. Second, the Anton module will be expanded, giving dietitians and foot care specialists advanced digital tools to assist in their work. Third, by March 2026, the company plans to launch insurance pilot programs in Hungary and a Western European country. This step is particularly important, as treating diabetes complications costs multiple times more than standard care, making group insurance coverage for people with diabetes nearly impossible or prohibitively expensive. Insurers are therefore actively seeking models that demonstrably reduce these risks.
Following this phase, MEROVA plans additional fundraising rounds to support international expansion and the broadening of its service portfolio, including the integration of in-house endocrinologists to make its annual preventive care package even more comprehensive.
“With MEROVA, we’re not only saving money, we’re saving lives,” emphasized the company’s leadership.